Should Boston Scientific (BSX) Investors Worry About These FDA Class II Recalls?

Boston Scientific (NYSE:BSX) reported multiple FDA-listed Class II recalls of its Neuromodulation system and Direxion Torqueable Microcatheters in 2026. The Neuromodulation system recall followed ...

What Is Medtronic (MDT) Facing After Two Class II Cardiac Device Recalls?

Medtronic (NYSE:MDT) initiated two Class II device recalls in November 2026 covering cardiac products used in implantable ...
Medical Daily

Recalled Newborn Breathing Circuits Land in the FDA's Middle Risk Tier After Reports of Connectors Melting

A study found summer food insufficiency rose 4 percentage points among low-income households with children, while first-year Summer EBT participation was low and showed no measurable effect. Federal ...